Publikationen
3390/ijerph19159126 Li J, Parrott S, Keding A, Dogar O, Gabe R, Marshall AM, (…) Boeckmann M , u. a. Cost-utility of cytisine for smoking cessation over and above behavioural support in people with newly [...] placebo-controlled phase 3 trial. Lancet Glob Health. 2020;8(11):e1408–17. doi: 10.1016/S2214-109X(20)30312-0 Ebi KL, Harris F, Sioen GB, Wannous C, Anyamba A, Bi P, (…) Boeckmann M , u. a. Transdisciplinary [...] m3811 Dogar O, Barua D, Boeckmann M , Elsey H, Fatima R, Gabe R, u. a. The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients